RPL26P30

Across TCGA pan-cancer cohorts, RPL26P30 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RPL26P30 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RPL26P30 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL26P30 expression acts as an unfavorable survival marker, although some lineages such as COAD and OV show a favorable association.

UVM, LIHC, and ESCA are the cancer types where RPL26P30 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Median	All	0.406	0.771	<.001	84	view →
LIHC	OS	Tertile	All	0.670	0.865	<.001	43	view →
ESCA	OS	Quartile	III,IV	0.377	0.723	.002	35	view →
COAD	DFS	Tertile	All	0.614	0.400	.001	32	view →
KIRP	DFS	Tertile	All	0.737	0.910	.005	26	view →
STAD	OS	Quartile	II,III,IV	0.543	0.828	.009	21	view →
OV	OS	Quartile	IV	0.890	0.618	.005	18	view →
LUAD	DFS	Median	III,IV	0.251	0.540	.019	17	view →
KIRC	DFS	Tertile	II,III,IV	0.527	0.742	.012	14	view →
MESO	OS	Median	All	0.489	0.595	.030	13	view →
KICH	DFS	Median	II,III,IV	0.705	0.959	.011	10	view →
THCA	DFS	Quartile	III,IV	0.882	0.468	.021	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RPL26P30–UVM (DFS)

Open the UVM breakdown →